0001209191-19-022390.txt : 20190402 0001209191-19-022390.hdr.sgml : 20190402 20190402161158 ACCESSION NUMBER: 0001209191-19-022390 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VIERLING JOHN CENTRAL INDEX KEY: 0001191859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 19724777 MAIL ADDRESS: STREET 1: 110 N GEORGE BURNS RD #D-4018 CITY: LOS ANGELES STATE: MD ZIP: 90048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-01 0 0001300699 Athenex, Inc. ATNX 0001191859 VIERLING JOHN C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Stock Option (Right to Buy) 12.06 2019-04-01 4 A 0 10000 0.00 A 2029-04-01 Common Stock 10000 10000 D This option vests in four equal annual installments beginning on April 1, 2020. /s/Teresa Bair, Attorney-in-Fact 2019-04-02